Growth Metrics

OmniAb (OABI) EBT Margin (2022 - 2026)

OmniAb (OABI) reported EBT Margin of 50.36% for Q1 2026, up 39033.0% year-over-year from N/an in Q1 2025, and up 71.0% on a QoQ basis from 173.66% in Q4 2025.

OmniAb (OABI) has 5 years of EBT Margin data on file, last reported at 50.36% in Q1 2026.

  • Quarterly EBT Margin rose 39033.0% year-over-year to 50.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 190.93% (up 6385.0% YoY) and the FY2025 annual result came in at 355.16%, down 8457.0% from the prior year.
  • EBT Margin rose to 50.36% in Q1 2026 per OABI's latest filing, from 173.66% in the prior quarter.
  • Across five years, EBT Margin topped out at 27.27% in Q4 2022 and bottomed at 789.91% in Q3 2025.
  • The 5-year median for EBT Margin is 215.76% (2022), against an average of 279.07%.
  • The widest annual swing landed in 2024, when EBT Margin plunged 52556 bps; it then soared 39033 bps in 2026.
  • Tracing OABI's EBT Margin over 5 years: stood at 27.27% in 2022, then tumbled by 1623 bps to 415.35% in 2023, then surged by 66 bps to 140.9% in 2024, then decreased by 23 bps to 173.66% in 2025, then surged by 71 bps to 50.36% in 2026.
  • Per Business Quant, the three latest OABI EBT Margin figures stand at 50.36% (Q1 2026), 173.66% (Q4 2025), and 789.91% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 41.95%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 18.99%
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn -50.36%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -50.36%
Dec 31, 2025 -173.66%
Sep 30, 2025 -789.91%
Jun 30, 2025 -404.31%
Mar 31, 2025 -440.68%
Dec 31, 2024 -140.90%
Sep 30, 2024 -457.36%
Jun 30, 2024 -203.95%
Mar 31, 2024 -567.69%
Dec 31, 2023 -415.35%
Sep 30, 2023 -347.67%
Jun 30, 2023 -261.50%
Mar 31, 2023 -42.14%
Dec 31, 2022 27.27%
Sep 30, 2022 -215.76%
Jun 30, 2022 -174.55%
Mar 31, 2022 -85.66%